Alle Storys
Folgen
Keine Story von Orion Corporation mehr verpassen.

Orion Corporation

Orion Diagnostica to Transfer Production From Oulunsalo to Turku

Espoo, Finland (ots/PRNewswire)

Negotiations have been completed
with the personnel representatives in Orion Diagnostica Oy, a
subsidiary of Orion Corporation, concerning operational
rearrangements at Orion Diagnostica's sites in Finland. As a result
of the negotiations, a decision has been made to transfer the
production operations of the Oulunsalo plant to Turku. There are 30
employees at the Oulunsalo site. Additionally, operational
improvements will be implemented at Orion Diagnostica's Espoo site
where the impact is estimated to be about 16 working years.
The reason for the measures is overcapacity at the production
plants in Turku and Oulunsalo as well as the decreased demand for
certain older-generation products manufactured at the Espoo plant,
which has led to permanently decreased workloads.
As announced by Orion's management when the negotiations were
introduced,  the company will try to avoid laying off staff by
utilising relocation  possibilities and by offering job opportunities
also in Orion's other  business divisions. All the persons whose
tasks will end in Oulunsalo and  Espoo will be offered an opportunity
to be either relocated to the site of  Orion Diagnostica in Turku or
to be recruited into jobs vacant elsewhere in  the Orion Group.
After the rearrangements, Orion Diagnostica will continue
operations in Finland at its sites in Espoo, Turku and Oulu, where
the product development unit in the Medipolis Research Center may
also offer new job opportunities for some people.
www.orion.fi

Contact:

Jukka Viinanen, President and CEO, Orion Corporation, phone
+358-10-429-3710. Jaakko Rissanen, President, Orion Diagnostica Oy,
phone +358-10-429-4858

Weitere Storys: Orion Corporation
Weitere Storys: Orion Corporation
  • 11.05.2005 – 08:04

    Orion Group Interim Report 1-3/2005

    Espoo, Finland (ots/PRNewswire) - Net sales of the Orion Group were EUR 465.3 (496.9) million, down by 6.4% due to decreased invoicing of the pharmaceutical distribution business. Group operating profit grew by 52.2% to EUR 50.8 (33.4) million, thanks to the favourable performance of Orion Pharma. Group profit before taxes was EUR 50.6 (33.0) million. Earnings per share were EUR 0.27 (0.17). Equity ratio was 40.7% ...

  • 08.04.2005 – 13:56

    Orion: Positive Profit Warning

    Espoo, Finland (ots/PRNewswire) - The operating profit of the Orion Group for the first quarter of 2005 seems to be clearly better than that in the comparative period last year, for which the consolidated operating profit in accordance with the IFRS came to EUR 33.4 million. The good profitability is mainly consequence of the continued good sales performance and successful cost management in the Orion Pharma business division. Also the full-year net sales and ...

  • 23.03.2005 – 08:01

    Erkki Etola Re-Elected Vice Chairman of Orion's Board of Directors

    Espoo, Finland (ots/PRNewswire) - At its meeting held yesterday evening, the Board of Directors of Orion Corporation, which was elected yesterday at the Annual General Meeting of Shareholders, has re-elected Erkki Etola as Vice Chairman. Orion Corporation Jukka Viinanen Olli Huotari President and CEO General Counsel ...